Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$25,236,288
-$5,700,366 QoQ
Shares Held
199,749
-10.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#294
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $996,376,961 across 14 Drug Manufacturers - General names. GILD ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300,851 | $360,849,743 | |
| 2 | JNJ |
Johnson & Johnson
|
1,286,261 | $326,671,705 | |
| 3 | ABBV |
AbbVie Inc.
|
323,203 | $81,330,801 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,084,726 | $62,501,910 | |
| 5 | MRK |
Merck & Co., Inc.
|
391,031 | $50,247,482 | |
| 6 | AMGN |
Amgen Inc
|
104,523 | $37,849,868 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
199,749 | $25,236,288 | |
| 8 | PFE |
Pfizer Inc
|
793,315 | $19,103,024 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,236,288 | 199,749 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $30,936,654 | 221,975 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $30,605,217 | 249,350 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $30,451,827 | 271,770 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,328,038 | 263,376 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,485,302 | 292,048 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,418,933 | 326,759 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,383,624 | 360,186 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $30,239,088 | 373,276 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $27,351,598 | 364,980 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $25,075,569 | 325,361 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $27,015,362 | 325,604 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,204,308 | 270,289 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,277,121 | 166,593 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $10,229,245 | 165,495 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,269,350 | 206,381 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,243,612 | 196,166 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,485,842 | 207,385 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,351,372 | 222,936 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,320,968 | 268,002 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $31,245,419 | 536,310 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $43,177,852 | 683,302 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $64,643,293 | 840,178 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $56,575,975 | 756,768 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||